BRIEF-Ono Pharmaceutical Co., Ltd.- Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean

Reuters · 1d ago

Please log in to view news